008930 — Hanmi Science Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Market Cap
KR₩3tn
Enterprise Value
KR₩3tn
Revenue
KR₩1tn

Annual income statement for Hanmi Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	857,383	950,165	1,046,054	1,247,906	1,283,432
Cost of Revenue
Gross Profit	120,716	132,771	160,373	235,590	242,612
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	824,881	897,226	967,258	1,107,050	1,195,089
Operating Profit	32,502	52,939	78,796	140,856	88,343
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	29,966	49,122	73,180	130,542	63,095
Provision for Income Taxes
Net Income After Taxes	22,597	42,940	69,035	115,120	56,693
Minority Interest
Net Income Before Extraordinary Items
Net Income	22,601	42,942	69,210	115,122	59,422
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	22,601	42,942	69,210	115,122	59,422
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	329	701	856	1,482	1,017
Dividends per Share